Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents

Clinical trial NCT03349346 · WITHDRAWN

Trial details

NCT number: NCT03349346
Sponsor: Gilead Sciences
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma Mediastinal B-cell Lymphoma

Start date: 2019-06-01
Primary completion: 2021-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.